Journal
NEUROPROTECTIVE AGENTS
Volume 1199, Issue -, Pages 95-104Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1749-6632.2009.05351.x
Keywords
cerebral ischemia; stroke; infarct size; ALCAR; microdialysis; glutamate
Categories
Ask authors/readers for more resources
Acetyl-L-carnitine (ALCAR), an endogenous water soluble molecule, is synthesized in the brain and is involved in many aspects of neuronal activity, including metabolism and neuronal membrane formation and integrity. To determine ALCAR's neuroprotective effects, focal cerebral ischemia was induced using four models of middle cerebral artery occlusion (MCAO) and treatment with 0-400 mg/kg ALCAR (i.p.) prior to MCAO. While acute doses were without effect, pretreatment with chronic ALCAR (400 mg/kg/day for five days) significantly reduced infarct size. Lower chronic ALCAR doses were not effective. Additionally, elevations in microdialysate glutamate post-MCAO were attenuated by ALCAR treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available